Last update: Aug. 27, 2014

Ivabradine

High Risk for breastfeeding


Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding several T½.
Read the Comment.

It selectively reduces the heart rate and it is used in the symptomatic relief of chronic stable angina with normal sinus rate in patients with beta-blocker intolerance.

No side effects on breastfeeding are known. Possible risk of bradycardia and arrhythmia

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Ivabradine belongs to this group or family:

Tradenames

Main tradenames from several countries containing Ivabradine in its composition:

Pharmacokinetics

Variable Value Unit
Bioavailability 40 %
Protein Binding 70 %
T1/2 11 hours

References

  1. Kearney L, Wright P, Fhadil S, Thomas M. Postpartum Cardiomyopathy and Considerations for Breastfeeding. Card Fail Rev. 2018 Abstract Full text (link to original source) Full text (in our servers)

Total visits

2,414

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche de México from Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM